Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update
Alpha Cognition Inc. (ACOG)
Company Research
Source: Business Wire
Alpha Cognition generated fourth quarter 2025 ZUNVEYL net product revenue of $2.5 million, contributing to full year 2025 total revenue of $10.2 millionFourth quarter bottles dispensed increased 62% quarter-over-quarter to 4,941, with December representing the strongest month since launchExecuted second national PBM contract and initiating three studies to further support ZUNVEYL’s positioning in long-term care Alzheimer’s patientsCash and cash equivalents totaled $66 million at year-end 2025, supporting the company’s continued target of operating profitability in 2027Company to host conference call and webcast today, March 26, at 4:30 p.m. ET VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (ACOG: NASDAQ) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today reported financial results for the fourth quarter and full year ended December 31, 2025
Show less
Read more
Impact Snapshot
Event Time:
ACOG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACOG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACOG alerts
High impacting Alpha Cognition Inc. news events
Weekly update
A roundup of the hottest topics
ACOG
News
- Alpha Cognition (ACOG) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=ACOG&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" MarketBeat
- Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury [Yahoo! Finance]Yahoo! Finance
- Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain InjuryBusiness Wire
- Alpha Cognition (ACOG) Q4 2025 Earnings Transcript [Yahoo! Finance]Yahoo! Finance
- Alpha Cognition Inc. (ACOG) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
ACOG
Earnings
- 3/26/26 - Miss
ACOG
Sec Filings
- 3/31/26 - Form 10-K
- 3/31/26 - Form 4
- 3/27/26 - Form 8-K
- ACOG's page on the SEC website